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Abstract
Identification of high affinity drug-target interactions (DTI) is a major research
question in drug discovery. In this study, we propose a novel methodology to predict
drug-target binding affinity using only ligand SMILES information. We represent pro-
teins using the word-embeddings of the SMILES representations of their strong binding
ligands. Each SMILES is represented in the form of a set of chemical words and a pro-
tein is described by the set of chemical words with the highest Term Frequency- Inverse
Document Frequency (TF-IDF) value. We then utilize the Support Vector Regression
(SVR) algorithm to predict protein - drug binding affinities in the Davis and KIBA
Kinase datasets. We also compared the performance of SMILES representation with
the recently proposed DeepSMILES representation and found that using DeepSMILES
yields better performance in the prediction task. Using only SMILESVec, which is
a strictly string based representation of the proteins based on their interacting lig-
ands, we were able to predict drug-target binding affinity as well as or better than the
KronRLS or SimBoost models that utilize protein sequence.
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Introduction
Identification of high affinity drug-target interactions is an important first step in the drug
discovery pipeline. The development of novel drugs is an expensive and resource-consuming
process and the repurposing/repositioning of existing approved drugs is a major alterna-
tive.1 Therefore, exploiting the available protein - drug interaction knowledge can provide
a good starting point in drug repurposing studies. Furthermore, understanding bimolecular
recognition between proteins and drugs can also provide valuable information for generation
of novel drugs using generative models.2–4
Drug-target interaction (DTI) prediction has often been investigated as a binary clas-
sification problem,5–11 but recent studies have also been focusing on the prediction of the
strength of the interaction between the drug and its target.12–14 Binding affinity is often
expressed in dissociation constant (Kd), inhibition constant (Ki), or the half maximal in-
hibitory concentration (IC50) values. The prediction of binding affinity for novel interactions
is still a challenging task because (i) representation of proteins and ligands in the computa-
tional space is complicated by the inherent three-dimensional nature of the binding, (ii) there
are only 14,761 protein - ligand complex structures in PDBBind15 in which the interaction
mode is reported (September 1st, 2018), (iii) the chemical space sampled by the currently
available data is limited, and (iv) the prediction algorithm needs to take the level of noise in
experimental measurements into account. As the number and reproducibility of the available
protein - ligand interaction data increases, utilizing this large data set provides access to a
larger chemical space, and a reduction in signal to noise ratio.
Recent studies employed deep learning architectures such as Convolutional Neural Net-
works (CNNs) to predict binding affinity2,16,17 utilizing 3D-based information of drug-target
complex to address point (i). The major drawback of these approaches is that the avail-
able information on 3D structure of the protein - compound complex is limited compared
to the sequence information of proteins and compounds as stated in point (ii). Therefore, a
sequence based approach can take advantage of the increasing wealth of information on pro-
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tein - drug recognition. String based approaches take advantage of the tools and algorithms
developed in the natural language processing (NLP) domain. The field of chemical linguis-
tics that brings the chemistry and linguistics domains together is growing since its initial
inception in the 1960s18 with efforts that focus on identifying information rich patterns and
important keywords that can then be used in comparison or search algorithms19,20 in infor-
mation retrieval and text mining problems,21 in prediction of chemical reaction outcomes,22
and even in proposing novel scaffolds by expanding the chemical space.23
In a recent study, our team proposed a CNN-based model to represent proteins based
on their sequence information and their interacting compounds using Simplified Molecular
Input Line Entry System (SMILES) form.14 The high-level representations were then fed
into a feed-forward neural network to predict drug-target binding affinity with a promising
performance. In this work, we observed that the protein sequences were hard to model even
when the powerful CNN architecture was used. Protein sequences contain binding regions
(residues) but these constitute a small fraction of the total sequence. Therefore, the noise to
signal ratio is higher for protein sequences, leading to lower performance. Furthermore, the
residues that participate in binding are usually not placed consecutively in the sequence due
to the folded nature of the protein, complicating the task to distinguish the patterns that
are active in binding.
In this study, we provide an alternative approach to represent proteins by their inter-
acting ligands instead of using their sequences. The chemical similarity of the interacting
ligands has been used to detect biologically and functionally similar proteins in many stud-
ies.24–27 Our team has recently shown that ligand-based protein representation produced
either comparable or better performance than sequence based representations in a protein
clustering task.27 Ligands were represented utilizing their SMILES forms, which were subse-
quently converted into high-dimensional vectors by the Word2Vec algorithm.28 We called this
method of ligand representation as SMILESVec. Behind the major popularity of Word2Vec
lies its capability to capture the semantic relationship between words that appear in similar
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contexts. In the chemical domain, this could be translated into the relationships between
chemical words that are extracted from SMILES strings to reveal specialized patterns. Even
if SMILES representations are not unique, we can capture relationships between “words”
(chemical words) that are placed in the same “sentence” (compounds) using Word2vec.
Motivated by the promising results of SMILESVec in the protein clustering task, here
we introduce a strictly SMILES-based methodology to predict drug-target binding affinity.
The novelty of this approach is that we combine the ligand-centric protein representation
based on SMILESVec with Term Frequency-Inverse Document Frequency (TF-IDF) weight-
ing.29,30 SMILESVec combines the high-dimensional vectors of the chemical words extracted
from SMILES to build a vector representation for the whole SMILES and the proteins are
represented as the average of the SMILESVec vector of their interacting ligands. In this study
however, we adopted two approaches; (i) instead of using the whole SMILES string of the
interacting ligands as in the original work, we determined a new set of chemical words that
are selected based on the TF-IDF weights of each word. Then, the top-K highest ranking
chemical words in terms of TF-IDF value are selected to represent the protein, (ii) instead
of using all interacting ligands (with either high or low binding affinity) we chose only the
ligands that bind to the protein with high affinity and similar to the first process, the chem-
ical words with higher TF-IDF values are chosen to represent the protein. Furthermore, we
adopted a recent approach that introduces a new syntax for SMILES representation, namely
DeepSMILES.31 DeepSMILES transforms the regular SMILES syntax by updating the use
of ring closure digits and paired parantheses that are used to represent branching.
We report the performance of SMILES-based drug-target binding affinity prediction on
two Kinase datasets, namely Davis32 and KIBA33 using Concordance Index (CI) and Mean
Squared Error (MSE) metrics. We compare our results with two recent state-of-art studies
that employ traditional machine learning methods to predict binding affinity of drug-target
pairs, namely KronRLS12 and SimBoost.13 Furthermore, a sequence-based protein repre-
sentation approach, ProtVec,34 which utilizes the Word2Vec algorithm on 3-residue protein
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sub-sequences, was chosen for comparison. We also included TF-IDF weighting in ProtVec
representation in order to choose higher weighted sub-sequences to represent the protein.
The results showed that representing proteins with the chemical words that are chosen
among their high-affinity interacting based on their TF-IDF weights outperformed the models
with a statistical significance where proteins are either represented with using ProtVec (p-
value of 0.0001 ) or using Protvec with and TF-IDF weights based sub-sequence selection
(p-value of 0.0001) on Davis dataset in terms of CI metric. Similarly in KIBA dataset,
SMILES-based approach reported to provide better performance over the ProtVec + TF-IDF
approach with a statistical significance in CI metric (p-value of 0.0001). Furthermore, the use
of the DeepSMILES syntax demonstrated an improvement over the model in which regular
SMILES was utilized and we obtained significantly better results than the KronRLS approach
and comparable performance to SimBoost. We propose that, only depending on compound
representation and ligand-binding information and without any feature engineering, we were
able to provide promising results in the prediction of binding affinity. More significantly, we
were able to show that the use of a set of important chemical words were successful enough
to describe a protein without any sequence or structure information.
Methods
Dataset
We used Davis,32 a selectivity assay data for Kinase family proteins, and KIBA33 as bench-
mark datasets to evaluate the proposed model. The Davis dataset includes 442 proteins and
68 compounds and the disassociation constant (Kd) values for about 30K interactions. We
converted Kd values to pKd as follows:
13
pKd = −log10(Kd
1e9
) (1)
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Figure 1: A) Distribution of binding affinity values in Davis dataset ( pKd). B) Distribution
of binding affinity values in KIBA dataset ( KIBA score).
Figure 1 illustrates the distribution of binding affinity values per DTI pairs in the bench-
mark datasets. The range of pKd values in Davis is 5 to 10.8, with more than half of the
interactions having pKd 5 as affinity value (20931 out of 30056), representing no or very
weak binding.
Ligand representation
In this study, we adopted a recent approach, SMILESVec, to describe chemical entities
based on their SMILES representations.27 SMILESVec utilizes the Word2Vec algorithm to
learn high-dimensional embeddings for the chemical words that are extracted from SMILES
strings as 8-character long overlapping substrings. Word2Vec is a type of neural-network
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that learns high-dimensional representations of words by training on a large text corpus.28
The model is successful at capturing the semantic similarity between words that appear in
similar contexts, since it considers the neighboring words of each word within a window
frame during training.
Figure 2: Learning embeddings for chemical words.
SMILESVec is described as in Equation 2, in which n is equal to the number of chemical
words (cw) extracted from the SMILES string of a compound and vector(cwk) represents
the embedding of the kth chemical word.27 Finally, the compound is described as the average
of the vectors of the chemical words in its SMILES representation.
SMILESV ec = vector(ligand) =
∑n
k=1 vector(cwk)
n
(2)
To train the Word2Vec algorithm, approximately 2M canonical SMILES strings from Pub-
chem database were used. We used the Gensim implementation35 of Word2Vec with the
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skip-gram approach and the size of the vectors was set to the default value of 100. Figure 2
illustrates the process of how the embeddings of the chemical words are created.
We also utilized a recent approach named DeepSMILES, that proposes a new syntax for
the representation of SMILES strings.31 DeepSMILES hypothesizes that the proposed syntax
will improve the performance of machine learning models that deal with SMILES strings
with the help of the modifications on the branch and ring representations in the SMILES.
Therefore, in order to investigate the effectiveness of the DeepSMILES syntax, we first
converted our training data of 2M canonical SMILES into DeepSMILES. Then, we created
8-charactered sub-sequences from each DeepSMILES to train the Word2Vec algorithm. The
ligand vector was created using Equation 2. We will refer to DeepSMILES-based embeddings
as DeepSMILES-Vec throughout the article.
Protein representation
In order to represent proteins, we adopted a ligand-centric approach, where a protein is
represented as a vector that is the average of the SMILESVec vectors of its interacting
ligands27. Different from our recent work in27, where all chemical words are considered to
be equally important, inspired from the Information Retrieval domain, we propose to weight
the chemical words using Term Frequency - Inverse Document Frequency (TF-IDF). Instead
of including all chemical words to the description of a protein, we investigate identifying
and including only the important chemical words. The TF weight describes the importance
of a chemical word based on the number of its occurrences. The TF weight of a chemical
word cw in the set of chemical words that are extracted from the SMILES of the interacting
ligands of a protein P is calculated as follows (Equation 3 ):
TFweightcw,P =

1 + log10(TFcw,P ), if TFcw,P > 0
0, otherwise
(3)
where TF refers to the number of occurrences of cw in that set of chemical words. IDF
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weight, on the other hand, assigns higher importance to the rare words in a corpus. It is
described as in Equation 4:
IDF (cw,D) = log
N
|s ∈ S : cw ∈ s| (4)
where cw, S and N denote the chemical word, SMILES corpus, and number of SMILES
in the corpus, respectively.30 To compute the IDF weights of the chemical words, we used
the same SMILES corpus (∼ 2M compounds from Pubchem) that we used to train the
Word2Vec algorithm. TF-IDF weighting is computed as the product of term frequency and
inverse document frequency for each chemical word.
Eventually, a protein is represented using the high (i.e., top K) TF-IDF weighted chemical
words in its interacting ligands. Let us assume the number of unique chemical words in a
set is represented with J . If the number of unique chemical words in the set is smaller than
K, then J number of words is used. The average of the corresponding embedding vectors is
assigned as the final protein vector (Equation 5). In this study K is set as 100.
vector(protein) =
∑K
k=1 vector(cwk)
min(J,K)
(5)
We also followed two strategies to choose the set of ligands used to represent a protein:
i) using all interacting ligands and ii) using the ligands with strong binding affinity values.
For the Davis dataset we selected the pKd value of 7 as threshold to divide the ligands
into strong-binding and weak-binding classes (pKd ≥ 7 strong binding),13 whereas for KIBA
dataset, KIBA value of 12.1 was chosen as threshold to choose between weak and strong
binding ligands.
If a protein interacts with at least one ligand from the high-binding class, then that ligand
is used to represent the protein. If not, the protein is represented with all of its interacting
ligands. Figure 3 visualizes how protein representation is built based on the SMILESVec
approach.
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protein =

high affinity ligands, if pKd ≥ 7
all interacting ligands, otherwise
Figure 3: SMILESVec + TFIDF based protein representation.
We compared our results with the ProtVec model,34 which is a protein sequence (FASTA)
based approach that uses the Word2Vec model. ProtVec defines proteins using the sub-
sequence embeddings that are trained on 3-residue sub-sequences of a large protein sequence
corpus. ProtVec uses all sub-sequences that are extracted from the protein sequence to
describe the protein. Equation 6 describes ProtVec in which m represents the number of
sub-sequences (ss) extracted from the protein sequence.
vector(protein) =
∑m
k=1 vector(ssk)
m
(6)
We also applied the TF-IDF weighting approach to select the top K sub-sequences with the
higher TF-IDF weights to represent proteins in which the number of unique sub-sequences
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are represented with J (Equation 7). K is chosen as 100 in this study.
vector(protein) =
∑K
k=1 vector(ssk)
min(J,K)
(7)
We collected 550K protein sequences from the UniProt database to train a Word2Vec
model and to learn representations for protein sub-sequences.
Protein-ligand representation
Proteins and ligands are both described with 100-dimensional real-valued word embeddings.
Therefore, the input for the prediction model is a 200-dimensional vector, which is equal to
the concatenation of the protein and ligand vectors for each protein-ligand pair.
Support Vector Regression (SVR)
Support Vector Machine (SVM) is a supervised learning model that allows mapping non-
linear data to the linear space with the use of kernel functions.36 Kernel function usage is one
of the major factors that makes SVM popular among the researchers. SVMs have two main
categories: Support Vector Classification (SVC) and Support Vector Regression (SVR). SVR
is a popular model among machine learning methodologies and has been successfully applied
to the bioactivity prediction task in the past.37 For the cases where the data is linearly
separable, our model is y(x) = wTx+ w0 and we aim to minimize the following function:
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min
1
2
||w||2 w.s.t rt(wTxt + w0) ≥ +1,∀t (8)
For the cases where data is not linearly separable, then slack variables γ are introduced
as the penalty of misclassification. We also use a penalty factor C and the problem becomes:
min
1
2
||w||2 + C
∑
tγt w.s.t rt(wTxt + w0) ≥ 1− γt (9)
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We used the Scikit-learn Python package implementation of SVR39 and utilized the radial
basis function kernel.
Evaluation
The performance of the proposed model was measured by calculating the Concordance Index
(CI) and Mean Squared Error (MSE) metrics. CI evaluates the performance of a model that
outputs continuous values,:40
CI =
1
Z
∑
δx>δy
h(bx − by) (10)
where bx is the prediction value for the larger affinity δx, by is the prediction value for
the smaller affinity δy, Z is a normalization constant, h(m) is the step function:
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h(m) =

1, if m > 0
0.5, if m = 0
0, if m < 0
MSE estimates the difference between the predicted values (p) and the vector of actual
values (y). n indicates the number of samples.
MSE =
1
n
n∑
k=1
(pk − yk)2 (11)
Results and discussion
With this study, we introduce a novel drug - target binding affinity prediction method
based only on SMILES string representation with which ligands and their target proteins are
represented. We adopted the Support Vector Regression (SVR) algorithm as the prediction
algorithm and performed our experiments on the Davis and KIBA Kinase datasets.
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Baseline: Protein sequence based methodologies
We compared the methods presented here with two studies that employ traditional ma-
chine learning learning models. These state of the art models were used as our baseline.
The first study uses Kronecker- Regularized Least Squares (KronRLS) algorithm to predict
binding affinity in which both proteins and compounds are represented with their pair-
wise similarity score matrices.12 In order to compute similarity between proteins and be-
tween compounds, Smith-Waterman (S-W) algorithm and PubChem structure clustering
tool (http://pubchem.ncbi.nlm.nih.gov) were utilized, respectively. In the second study, a
gradient boosting machine based method, namely SimBoost, is employed for the prediction of
the binding affinity.13 The presented approach depends on feature engineering of compounds
and proteins utilizing information such as similarity and network-inferred statistics.
Experiment Settings
We evaluated the performance of the presented models on the benchmark datasets Davis32
and KIBA33 and used the same training and test folds that were used in our previous work14
(https://github.com/hkmztrk/DeepDTA). In these folds, both datasets were randomly di-
vided into six equal parts and one part was separated as the independent test set. The
remaining parts of the data set were used to determine the hyper-parameters C and γ
via five-fold cross validation. We chose the values for C and γ among 0.01, 1.0, 100.0 and
0.1, 1.0, 10.0, respectively. The parameter combination with which we obtained the best
CI value on the training set was selected to model the test set. We performed statistical
significance tests with paired t-test with the 95% confidence interval.
Results
In this study, we propose a model to predict the binding affinity of drug-targets using only
SMILES strings to represent both compounds and proteins. Proteins are represented either
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with their strong affinity ligands or with all tested ligands (including weak binding values).
In the Davis dataset, 20931 out of 30056 of drug-target pairs have affinity value of 10000
nM (pKd=5) indicating weak or no interaction. The average number of ligands a protein
binds with strong affinity (above value of 7) is 5.5 in Davis dataset. In KIBA dataset, on the
other hand, the average number of interacting ligands is 516.4 and 99.2 out of 2111 ligands
have high affinity (affinity above value of 12.1 KIBA score).
Tables 1 and 2 report the average MSE and CI scores over the independent test set
for baseline models and the total five different approaches that use SVR for the prediction
of binding affinity for Davis and KIBA datasets, respectively. In the first model (1), the
proteins are represented with ProtVec method that is based on a high-dimensional vector
as the average of the embedding vectors of the all 3-residue sub-sequences extracted from
the protein sequence.34 The second model (2) not only utilizes ProtVec approach but also
incorporates TF-IDF weights to identify the top-K important sub-sequences with which the
protein is represented (Equation 7). Therefore, instead of using all protein sub-sequences,
the second model uses only 100 sub-sequences in order to describe proteins.
In the third model (3) the ligand-centric SMILESVec approach is employed in which all
interacting ligands of a protein are considered ( including ligands with 10000 nM (pKd =
5)affinity) and the top-K chemical word with the highest TF-IDF values are assigned to
represent proteins. Note that, because the affinity value is reported, this would be similar to
a real-world scenario in which all compounds with an affinity value are utilized. The fourth
model (4) adopts a similar approach to Model (3), except only ligands that bind to the
protein with high affinity that is equal to or higher than the threshold value (pKd ≥ 7 for
Davis, KIBA ≥ 12.1 for KIBA ) are considered to represent the protein . However, for the
cases where protein does not have any interactions with affinity higher than the threshold,
then all interacting ligands of the protein are considered. In the fifth model (5), proteins
are described with the high TF-IDF weighted chemical words present in their strong binding
ligands. The difference of this model from model (4) is that instead of regular SMILES
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syntax, compounds are represented with DeepSMILES syntax (DeepSMILES-Vec). In all of
the five models, ligands are represented as the average of the embeddings of their chemical
words (i.e. all chemical words extracted from SMILES are considered).
Table 1: CI and MSE values for Davis dataset on the independent test set using SVR
algorithm. Standard deviations are given in the parenthesis. (A: refers to all ligands, SB:
refers to strong-binding ligands)
Method Proteins Compounds CI MSE
KronRLS12 S-W PubChem Sim 0.871 (0.0008) 0.379
SimBoost13 S-W PubChem Sim 0.872 (0.002) 0.282
SVR (1) ProtVec SMILESVec 0.801 (0.002) 0.552 (0.005)
SVR (2) Protvec+TF-IDF SMILESVec 0.824 (0.003) 0.423 (0.004)
SVR (3) SMILESVec+TF-IDF (A) SMILESVec 0.691 (0.013) 0.763 (0.001)
SVR (4) SMILESVec+TF-IDF (SB) SMILESVec 0.851 (0.0009) 0.394 (0.004)
SVR (5) DeepSMILES-Vec+TF-IDF (SB) SMILESVec 0.871 (0.004) 0.232 (0.004)
We observe that even though limited number of protein sub-sequences were used, using
the top-K sub-sequences with high TF-IDF weights (Model (2)) yielded better results than
plain ProtVec (Model (1)) in terms of both CI and MSE (Table 1). We can suggest that the
use of TF-IDF weights to choose representative sub-sequences for the description of proteins
provides more insight to the prediction model. The results also show that Model (4), in
which proteins are represented with the top-K chemical words with high TF-IDF weights that
are chosen among their strong-binding ligands outperforms the other models. CI and MSE
performances of the Model (4) are better than that of Model (2) with a statistical significance
(p-value 0.0001 for both metrics). Even without the use of sequence information, SMILES-
based representation approach provides promising results for the prediction of drug-target
binding affinity.
On the other hand, the worst CI and MSE performances are obtained when all interact-
ing ligands are used in Model (3). In Davis dataset, all protein-ligand interactions have an
affinity value, including the ones with the value of 10000 nM to indicate the absence of inter-
action or weak interaction. Model (3) simply makes use of the available affinity information.
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Public databases such as ChEMBL41 and PubChem42 provide the affinity value for a given
experiment. Not surprisingly, the use of strong-binding ligands to describe proteins led to a
higher performance than using all tested ligands. Comparing the performance of Model (4)
with state-of-art models in the task of drug-target binding affinity prediction on Davis set,
we observe that even with a strictly SMILES-based approach, Model (4) provides compara-
ble CI value and better MSE performance (0.871, 0.232) to KronRLS (0.871, 0.379)12 and
SimBoost (0.872, 0.282)13 approaches both of which utilize sequence information of proteins.
Table 2: CI and MSE values for KIBA dataset on the independent test set using SVR
algorithm. Standard deviations are given in the parenthesis. ( SB: refers to strong-binding
ligands))
Method Proteins Compounds CI MSE
KronRLS12 S-W Pubchem Sim 0.782 (0.0009) 0.411
SimBoost13 S-W Pubchem Sim 0.836 (0.001) 0.222
SVR (2) ProtVec+TF-IDF SMILESVec 0.742 (0.004) 0.439 (0.001)
SVR (4) SMILESVec+TF-IDF (SB) SMILESVec 0.823 (0.0004) 0.300 (0.0008)
SVR (5) DeepSMILES-Vec+TF-IDF (SB) SMILESVec 0.830 (0.0008) 0.235 (0.001)
Based on the results we obtained on Davis dataset, we repeated our experiments with
Models (2), (4) and (5) on KIBA dataset. We observe statistically significant improvements
with SMILESVec-based model (4) over Protvec-based model (2) in CI and MSE values
(p-value of 0.0001 for both) and over KronRLS-based approach in CI metric (p-value of
0.0001). The results indicate that DeepSMILES-Vec based approach produces a comparable
performance to the recent state-of-art machine learning approach SimBoost.
In conclusion, even without the use of protein sequence, we were able to define proteins
with the important chemical words that are extracted from their ligands. The use of TF-IDF
weighting to identify the significant chemical words proved to be a useful approach compared
to the model in which all chemical words were used. We also observed an improvement in
the models when DeepSMILES syntax was used instead of regular SMILES syntax. We hy-
pothesize that when also combined with the DeepSMILES-based compound representation,
prediction performance of the proposed model (5) could improve.
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Chemical words
In this study, we used two different SMILES syntax to describe the compounds which in turn
were utilized to build representations for their interacting proteins. DeepSMILES is proposed
recently in order to transform regular SMILES into a more machine-learning friendly syntax.
The use of single ring closure and the utilization of ’close parenthesis’ instead of paired
parantheses are the major novel features of DeepSMILES syntax.
As a case study, we selected ALK tyrosine Kinase (UniProt ID:Q9UM73) and inspected
the top-five chemical words with the highest TF-IDF values that are used to represent this
protein when only strong-binding ligands are considered. The words were, ’6=O)(CO)’,
’C6=O)(CO’, ’C53)CNC6’, ’53)CNC6=’, ’=C53)CNC’. Further investigation revealed that
“C6=O)(CO” and “6=O)(CO)” appear only in one ligand, named Lestaurtinib (PubChem
identifier, 126565) out of 66 unique strong binding ligands, whereas “53)CNC6=”, “=C53)CNC”,
and “C53)CNC6” appear in three ligands with Pubchem identifiers 126565 (Lestaurtinib),
51004351 and 44259 (Staurosporine), all of which are indolocarbozole derivatives.
We then investigated the top-five chemical words with highest TF-IDF values that
were extracted from DeepSMILES-Vec based representation, which were ’CC=C6N%2’,
’13%20)))’, ’3%20))))’, ’C%13%20)’, ’%13%20))’ . We observed that all of these chemical
words are present in only three ligands with PubChem identifiers 126565, 51004351 and
44259. We should note that these three ligands were also identified using SMILES but the
chemical words and their corresponding weights were eventually different.
We also analyzed the KIBA dataset in terms of chemical words that are created from
SMILES and DeepSMILES syntax on Cyclin-dependent Kinase 1 (CDK1) (UniProt identi-
fier, P06493). With SMILES, the top-five chemical words were ’N)C)C(=N’, ’3)NN=C4N’,
’(C=C3)NN’, ’C3)NN=C4’, ’)OCC(CC4’ . These words were observed in 6, 25, 38, 49, and
10 unique ligands, respectively. With DeepSMILES, on the other hand, the top-five chemical
words were ’))NN=C5N’, u’CC6=NN9)’, u’6))NN=C5’, u’NN9)))))’, u’N=C6)))O’ . These
chemical words were observed in 38, 19, 64, 20, and 12 unique ligands, respectively. The
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fact that top-five chemical words are observed in more ligands when DeepSMILES is used
suggests that the generalization provided by DeepSMILES is useful for the identification
of otherwise undetectable patterns. For example, DeepSMILES assigns different notations
of benzene such as ’c1ccccc1’ ’c2ccccc2’ to the same ”ccccccc6” representation. Hence, the
carbon numbering in SMILES is replaced such that synonomous groups have the same rep-
resentation in DeepSMILES, allowing more powerful identification of repeated features.
Conclusion
With this study, we proposed a novel approach to predict drug-target binding affinity by
representing proteins with the chemical words of their high affinity ligands. These chemical
words, which are 8-character sub-sequences extracted from SMILES of the ligands, are ranked
based on TF-IDF weights and, then high-ranking top-K chemical words are selected to
describe the protein. The average of the word embeddings for each corresponding chemical
word defines the final protein vector. Compounds, on the other hand, are represented as
the average of all of their chemical words extracted from their SMILES. The combination of
protein and drug vectors defines each drug-target pair. Support Vector Regression (SVR) is
then utilized in the drug-target affinity prediction task.
We were able to predict drug-target binding affinity using only SMILES strings without
using any protein sequence or structure information. As expected, using only the high
affinity ligands in the protein representation provides a significantly better performance than
using all available or tested ligands. Furthermore, the use of TF-IDF weights to determine
the most informative protein sub-sequences in protein representation provided significant
improvement for the prediction task. We also showed that a recently introduced syntax for
SMILES, DeepSMILES, provides better performance than regular SMILES.
The power of the ligand based representation lies in its ability to describe functional
properties of a protein. A limitation of our approach is that it is only available for datasets
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that have proteins with at least one ligand interaction. On the other hand, structure based
prediction tools are limited by the small number of protein - drug complex structures. Our
results suggest that adding our ligand centric approach to approaches that utilize orthogonal
pieces of information such as 3D structure of the complex, or binding site residues on the
protein can provide significant depth to our understanding of the mechanism of protein -
drug recognition.
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